Correlation Between Aerovate Therapeutics and Oncorus

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Oncorus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Oncorus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Oncorus, you can compare the effects of market volatilities on Aerovate Therapeutics and Oncorus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Oncorus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Oncorus.

Diversification Opportunities for Aerovate Therapeutics and Oncorus

-0.51

Correlation Coefficient

Aerovate Therapeutics  Oncorus

Excellent diversification

The 3 months correlation between Aerovate and Oncorus is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Oncorus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncorus and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Oncorus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncorus has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Oncorus go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Oncorus

If you would invest  150.00  in Aerovate Therapeutics on September 22, 2024 and sell it today you would earn a total of  103.00  from holding Aerovate Therapeutics or generate 68.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	0.79%
Values	Daily Returns

Aerovate Therapeutics  vs.  Oncorus

Aerovate Therapeutics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Oncorus

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncorus has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Oncorus is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Aerovate Therapeutics and Oncorus

The main advantage of trading using opposite Aerovate Therapeutics and Oncorus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Oncorus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncorus will offset losses from the drop in Oncorus' long position.

The idea behind Aerovate Therapeutics and Oncorus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.